BioSpace News Archive

First Animal Rescue and Protection Organization in Country To Receive Purple Heart Entity Status

Today, the Muscular Dystrophy Association (MDA) launched an extensive campaign to raise awareness about amyotrophic lateral sclerosis (ALS), with a focus on how innovative research and technology are bringing researchers one step closer to the next breakthrough and how MDA’s multidisciplinary Care Center network is extending patients’ lives.

Centric Medical, the Foot & Ankle division of Life Spine, Inc., which focuses on developing surgical implants for the treatment of distal extremity pathology announced today the commercial launch of its MTP Plating System

The U.S. Food and Drug Administration today announced it has authorized the marketing of new tobacco products manufactured by Philip Morris Products S.A. for the IQOS “Tobacco Heating System” – an electronic device that heats tobacco-filled sticks wrapped in paper to generate a nicotine-containing aerosol.

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) tablets to treat all six genotypes of hepatitis C virus (HCV) in children ages 12 to 17

During the month of May NAMI, the National Alliance on Mental Illness, will launch the WhyCare? awareness campaign for Mental Health Month.

3-V Biosciences, Inc. and Ascletis Pharma Inc. announced that 3-V Biosciences has recently dosed its first patient in a Phase 2 clinical trial of the FASN inhibitor TVB-2640 in patients with non-alcoholic steatohepatitis.

Amgen announced financial results for the first quarter of 2019.

Revenue increased 34% year over year to $9.2 million

Net loss was ($297,000), or ($0.01) per fully diluted common share; non-GAAP net income was $1.5 million, or $0.04 per fully diluted common share